Atypical Teratoid Rhabdoid Tumor

general

An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.

57

Centers

44

Active Trials

$7.6B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Atypical Teratoid Rhabdoid Tumor(57)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.2
2
NCI Comprehensive
Active Research Program
68.7
3
NCI Comprehensive
Active Research Program
68.7
4
NCI Comprehensive
Active Research Program
49.2
5
NCI Comprehensive
Active Research Program
49.2
6
NCI Comprehensive
Active Research Program
49.2
7
NCI Comprehensive
Active Research Program
49.2
8
NCI Comprehensive
Active Research Program
49.2
9
NCI Comprehensive
Active Research Program
49.2
10
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.2
11
Active Research Program
49.2
12
Active Research Program
49.2
13
Active Research Program
49.2
14
Active Research Program
49.2
15
NCI Comprehensive
Active Research Program
48.7
16
17
NCI Comprehensive
18
NCI Comprehensive
19
20
21
22
23
24
NCI Comprehensive
25
NCI Clinical
26
NCI Comprehensive
27
NCI Comprehensive
28
29
NCI Comprehensive
30
Cedars-Sinai CancerLos Angeles, CA
31
32
NCI Comprehensive
33
34
35
NCI Comprehensive
36
NCI Comprehensive
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
38
39
40
41
NCI Comprehensive
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
BC CancerVancouver, BC

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →